Dr Anthony S Fauci, Director, NIAD delivered the Rama-Robbins lecture during the 29th Joint Working Group meeting of VAP held on April 11-12, 2017 at NIAID, NIH, USA.
During this two day meeting a Joint Statement for extension of VAP programme for a period of five years till 2022 was signed between Prof. K. VijayRaghavan, Secretary DBT and Dr. Anthony S. Fauci, Director, NIAID, NIH, USA.
The Department of Biotechnology is implementing a bilateral programme called Indo-US Vaccine Action Programme, (VAP) with National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Department of Health and Human Services (DHHS), USA since July, 1987. The program supports a broad spectrum of activities relating to new and improved vaccines.
The program was designed to encompass laboratory-based research, evaluation of candidate vaccine development, testing for clinical development, vaccine quality control, delivery of vaccines etc. All work is carried out within areas designated as VAP priorities by the VAP Joint Working Group (JWG) which is composed of eminent scientists and policymakers from both the countries.